Literature DB >> 17076965

A pilot study to investigate the effectiveness of emotion recognition remediation in schizophrenia using the micro-expression training tool.

Tamara A Russell1, Elvina Chu, Mary L Phillips.   

Abstract

OBJECTIVE: Emotion recognition impairments are a common feature of schizophrenia. This pilot study investigates the effectiveness of the 'micro-expressions training tool' (METT) to help improve this skill.
METHOD: Twenty patients with schizophrenia and 20 healthy matched control participants completed the assessment, training and practice subsections of the METT. They were additionally evaluated pre- and post-training on an emotion-matching task (EMT).
RESULTS: Both groups improved with METT training; patients with schizophrenia improved to a level that did not distinguish them from pre-trained controls (on both METT and EMT assessments).
CONCLUSIONS: Patients with schizophrenia make significant improvements in emotion recognition following training with this tool, suggesting that brief remediation therapy may be a valuable adjunct to existing treatment programmes.

Entities:  

Mesh:

Year:  2006        PMID: 17076965     DOI: 10.1348/014466505X90866

Source DB:  PubMed          Journal:  Br J Clin Psychol        ISSN: 0144-6657


  22 in total

Review 1.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

2.  Social-cognitive remediation in schizophrenia: generalization of effects of the Training of Affect Recognition (TAR).

Authors:  Wolfgang Wölwer; Nicole Frommann
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

3.  A novel, online social cognitive training program for young adults with schizophrenia: A pilot study.

Authors:  Mor Nahum; Melissa Fisher; Rachel Loewy; Gina Poelke; Joseph Ventura; Keith H Nuechterlein; Christine I Hooker; Michael F Green; Mike Merzenich; Sophia Vinogradov
Journal:  Schizophr Res Cogn       Date:  2014-03-01

Review 4.  The functional significance of social cognition in schizophrenia: a review.

Authors:  Shannon M Couture; David L Penn; David L Roberts
Journal:  Schizophr Bull       Date:  2006-08-17       Impact factor: 9.306

5.  Restricted attention to social cues in schizophrenia patients.

Authors:  Alexandra Nikolaides; Susanne Miess; Isabella Auvera; Ralf Müller; Joachim Klosterkötter; Stephan Ruhrmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-06-15       Impact factor: 5.270

6.  A meta-analysis of emotion perception and functional outcomes in schizophrenia.

Authors:  Farzin Irani; Sarah Seligman; Vidyulata Kamath; Christian Kohler; Ruben C Gur
Journal:  Schizophr Res       Date:  2012-02-15       Impact factor: 4.939

7.  A Web-based Game for Teaching Facial Expressions to Schizophrenic Patients.

Authors:  Kemal Hakan Gülkesen; Filiz Isleyen; Buket Cinemre; Mehmet Kemal Samur; Semiha Sen Kaya; Nese Zayim
Journal:  Appl Clin Inform       Date:  2017-07-12       Impact factor: 2.342

Review 8.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

9.  A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.

Authors:  Cristina Cacciotti-Saija; Robyn Langdon; Philip B Ward; Ian B Hickie; Elizabeth M Scott; Sharon L Naismith; Loretta Moore; Gail A Alvares; Marie Antoinette Redoblado Hodge; Adam J Guastella
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

10.  Attentional-shaping as a means to improve emotion perception deficits in schizophrenia.

Authors:  Dennis R Combs; Aneta Tosheva; David L Penn; Michael R Basso; Jill L Wanner; Kristen Laib
Journal:  Schizophr Res       Date:  2008-06-27       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.